Identification of a nuclear receptor for bite acids

Science

Volumn 284, Issue 5418, 1999, Pages 1362-1365

  Makishima, Makoto ^a   Okamoto, Arthur Y ^b   Repa, Joyce J ^a   Tu, Hua ^b   Learned, R Marc ^b   Luk, Alvin ^b   Hull, Mitchell V ^b   Lustig, Kevin D ^b   Mangelsdorf, David J ^a   Shan, Bei ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL 7ALPHA MONOOXYGENASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; REPORTER GENE;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HOMEOSTASIS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; LIGANDS; LIVER; MEMBRANE GLYCOPROTEINS; MICE; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SYMPORTERS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033591297     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5418.1362     Document Type: Article

References (36)

1. D. J. Peet, B. A. Janowski, D. J. Mangelsdorf, Curr. Opin. Genet. Dev. 8, 571 (1998).
2. D. W. Russell and K. D. R. Setchell, Biochemistry 31, 4737 (1992).
3. B. A. Janowski, P. J. Willy, T. Rama-Devi, J. R. Falck, D. J. Mangelsdorf, Nature 383, 728 (1996); D. J. Peet et al., Cell 93, 693 (1998); J. M. Lehmann et al., J. Biol. Chem. 272, 3137 (1997).
4. B. A. Janowski, P. J. Willy, T. Rama-Devi, J. R. Falck, D. J. Mangelsdorf, Nature 383, 728 (1996); D. J. Peet et al., Cell 93, 693 (1998); J. M. Lehmann et al., J. Biol. Chem. 272, 3137 (1997).
5. B. A. Janowski, P. J. Willy, T. Rama-Devi, J. R. Falck, D. J. Mangelsdorf, Nature 383, 728 (1996); D. J. Peet et al., Cell 93, 693 (1998); J. M. Lehmann et al., J. Biol. Chem. 272, 3137 (1997).
6. B. M. Forman et al., Cell 81, 687 (1995).
7. W. Seol, H.-S. Choi, D. D. Moore, Mol. Endocrinol. 9, 72 (1995).
8. D. J. Mangelsdorf and R. M. Evans, Cell 83, 841 (1995).
9. A. M. Zavacki et al., Proc. Natl. Acad. Sci. U.S.A. 94, 7909 (1997).
10. T. Kanda et al., Biochem. J. 330, 261 (1998).
11. N. F. LaRusso, N. E. Hoffman, A. F. Hofmann, T. C. Northfield, J. L. Thistle, Gastroenterology 69, 1301 (1975).
12. J. J. Repa, M. Makishima, D. J. Mangelsdorf, unpublished material.
13. Y. Akashi, H. Miyazaki, F. Nakayama, Clin. Chim. Acta 133, 125 (1983).
14. S. A. Oñate, S. Y. Tsai, M. J. Tsai, B. W. O'Matley, Science 270, 1354 (1995); C. K. Glass, D. W. Rose, M. G. Rosenfeld, Curr. Opin. Cell Biol. 9, 222 (1997).
15. S. A. Oñate, S. Y. Tsai, M. J. Tsai, B. W. O'Matley, Science 270, 1354 (1995); C. K. Glass, D. W. Rose, M. G. Rosenfeld, Curr. Opin. Cell Biol. 9, 222 (1997).
16. P. J. Willy et al., Genes Dev. 9, 1033 (1995).
17. B. D. Darimont et al., ibid. 12, 3343 (1998); E. M. McInerney et al., Ibid., p. 3357.
18. B. D. Darimont et al., ibid. 12, 3343 (1998); E. M. McInerney et al., Ibid., p. 3357.
19. G. C. Zhou et al., Mol. Endocrinol. 12, 1594 (1998).
20. J. R. Crowther, ELISA: Theory and Practice, vol. 42 in Methods in Molecular Biology (Humana, Totowa, NJ, 1995).
21. C. J. Sippel, P. A. Dawson, T. Shen, D. H. Perlmutter, J. Biol. Chem. 272, 18290 (1997); M. H. Wong, P. Oelkers, P. A. Dawson, ibid. 270, 27228 (1995); A. L. Craddock et al., Am. J. Physiol. 274, C157 (1998).
22. C. J. Sippel, P. A. Dawson, T. Shen, D. H. Perlmutter, J. Biol. Chem. 272, 18290 (1997); M. H. Wong, P. Oelkers, P. A. Dawson, ibid. 270, 27228 (1995); A. L. Craddock et al., Am. J. Physiol. 274, C157 (1998).
23. C. J. Sippel, P. A. Dawson, T. Shen, D. H. Perlmutter, J. Biol. Chem. 272, 18290 (1997); M. H. Wong, P. Oelkers, P. A. Dawson, ibid. 270, 27228 (1995); A. L. Craddock et al., Am. J. Physiol. 274, C157 (1998).
24. D. J. Parks et al., Science 284, 1365 (1999).
25. K. D. Lustig and B. Shan, unpublished material.
26. Y. Z. Gong, E. T. Everett, D. A. Schwartz, J. S. Norris, F. A. Wilson, Proc. Natl. Acad. Sci. U.S.A. 91, 4741 (1994).
27. M. W. Crossman, S. M. Hauft, J. I. Gordon, J. Cell Biol. 126, 1547 (1994).
28. S. D. Turley and J. D. Dietschy, in The liver: Biology and Pathobiology (Raven, New York, ed. 2, 1988), chap. 34; A. F. Hofmann, in The Liver Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 38; M. C. Carey and W. C. Duane, in The Liver: Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 39.
29. S. D. Turley and J. D. Dietschy, in The liver: Biology and Pathobiology (Raven, New York, ed. 2, 1988), chap. 34; A. F. Hofmann, in The Liver Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 38; M. C. Carey and W. C. Duane, in The Liver: Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 39.
30. S. D. Turley and J. D. Dietschy, in The liver: Biology and Pathobiology (Raven, New York, ed. 2, 1988), chap. 34; A. F. Hofmann, in The Liver Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 38; M. C. Carey and W. C. Duane, in The Liver: Biology and Pathobiology (Raven, New York, ed. 3, 1994), chap. 39.
31. CV-1 cells were cotransfected with a rat FXR expression plasmid, a luciferase reporter construct containing five copies of an IR-1 response element, and a β-galactosidase (β-Gal) expression vector as a marker as described (4, 13). Transacted cells were treated with various compounds (Sigma) for 36 hours and then harvested for luciferase assay. For HepG2 cells cotransfected with human FXR, the luciferase reporter plasmid contained three copies of the IR-1 (AG-GTCAATGACCT), and cells were treated for 20 hours with compounds before being harvested. Cotransfections with Gal4-receptor chimeras included a luciferase reporter gene (G5-Luc) containing five copies of the Gal4 DNA binding site. Transfection data were normalized to β-Gal, are expressed relative to ethanol solvent controls as fold induction or relative light units (RLUs), and represent triplicate assays ± SD.
32. HEK-293 cells were transfected with plasmids expressing the chimeric proteins Gal4-SRC-1 (amino acids 583 through 783), FXR (amino acids 105 through 472)-VP16, and the G5-Luc reporter. Luciferase activity was measured as in (23).
33. The FXR LBD (amino acids 105 through 472) was fused to the COOH-terminus of glutathione S-transferase (GST), and the resultant GST-FXR protein was expressed in Escherichia coli and then purified on glutathione beads. For the FRET assay, a europiumlabeled antibody to GST [anti-GST-(Eu)] (Wallac, Gaithersburg, MD) was used to tag GST-FXR. SRC-1 (amino acids 595 through 822) was tagged with hexahistidine, expressed in E. coli, purified by metal ion chromatography, biotinylated, and labeled with fluorophore allophycocyartin (APC) (Wallac) conjugated to streptavidin. FRET occurs in solution when ligand-mediated changes in the conformation of FXR increase its affinity for SRC-1, resulting in energy transfer from europium (337 nm excitation and 620 nm emission) to APC (620 nm excitation and 665 nm emission). Results are expressed as a ratio of APC to europium fluorescence (665 nm/620 nm). To each well of a black polypropylene 96-well plate was added 10 nM GST-FXR, 100 nM biotin-SRC-1, anti-GST-(Eu) (0.2 μg/ml), APC-streptavidin (1 μg/ml), and the indicated compound In 100 μl of buffer [100 mM Hepes (pH 7.6), 0.125% CHAPS, and 125 mM NaF]. The reaction was mixed and incubated for 12 hours at 4°C and fluorescence was measured on a Victor II plate reader (Wallac). For ELISA, 1.5 μM biotin-labeled peptide (amino acid sequence Ile-Leu-Arg-Lys-Leu-Leu-Gln-Glu) was incubated with 100 nM GST-FXR and the indicated compound in 100 μl of buffer [25 mM tris-HCl (pH 7.4) and 150 mM NaCl] in a 96-well plate for 1 hour. The plate was washed and incubated with rabbit antibody to GST, and GST-FXR protein bound to streptavidin was quantitated with a horseradish peroxidase-labeled antibody to rabbit.
34. 496-Luc reporter by site-directed mutagenesis within the I-BABP promoter sequence -142 to -130 (Fig. 2A), which converts nucleotides AGGTGAATAACCT to ACCTGAATAAGGT.
35. Human Cyp7a mRNA was quantitated from HepG2 cells that were treated with the indicated compounds using a TaqMan One Step Gold reverse transcriptase (RT) PCR kit (Applied Biosystems/Perkin Elmer). The Cyp7a primers used were CYP7-78: 5′-TGATTT-GGGGGATTGCTATA; CYP7-178: 5′-CATACCTGGGC-TGTGCTCT; and CYP7-132(FAM): 5′- (6-FAM) TGGT-TCACCCGTTTGCCTTCTCCT (TAMRA). Analysis was performed in triplicate parallel assays.
36. We gratefully acknowledge the late Kazuhiko Umesono, whose pioneering work in the nuclear receptor field inspired much of this work. We thank A. Bronson, J. Bembenek, T. Lu, J. Wu, R. Daly, and L. Miao for reagents, technical support, and helpful discussions; D. Russell for the human Cyp7a promoter and critical comments; and C. Weinberger for rat FXR. M.M. and J.J.R. are associates and D.J.M is an investigator of the Howard Hughes Medical Institute. D.J.M. is supported by a grant from the Robert A. Welch Foundation.